APPLICATION
ANDA077906
TYPE
ANDA
ORIGINAL APPROVAL
2007-05-15
LATEST ACTION
2025-05-08
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
CAFFEINE CITRATEPrescription
CAFFEINE CITRATE EQ 30MG BASE/3ML (EQ 10MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2025-05-08Labeling · Supplement 4 · standardAP
2025-05-08Labeling · Supplement 3 · standardAP
2007-05-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.